Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Peripheral Nerve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02615106
What this trial is testing

Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma

Who this might be right for
Neuroblastoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 60
Not applicableLooking for participantsNCT07364955
What this trial is testing

Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma

Who this might be right for
Vestibular SchwannomaVestibular Schwannomas
Albert Torrents Torrero 75
Early research (Phase 1)Study completedNCT01576692
What this trial is testing

Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Testing effectiveness (Phase 2)Study completedNCT02129647
What this trial is testing

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Who this might be right for
Neurofibromatosis Type 2Vestibular Schwannomas
NYU Langone Health 13
Testing effectiveness (Phase 2)Ended earlyNCT00003552
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma

Who this might be right for
Stage IV MelanomaRecurrent Melanoma
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Study completedNCT00024258
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
Memorial Sloan Kettering Cancer Center 22
Early research (Phase 1)Study completedNCT02761915
What this trial is testing

A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

Who this might be right for
Relapsed or Refractory Neuroblastoma
Cancer Research UK 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868
What this trial is testing

APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Who this might be right for
Unresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more
Ascentage Pharma Group Inc. 230
Early research (Phase 1)Study completedNCT01662804
What this trial is testing

Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 14
Not applicableStudy completedNCT02864563
What this trial is testing

Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification

Who this might be right for
Neuroblastoma
Institut Curie 560
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00005955
What this trial is testing

Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Duke University
Not applicableLooking for participantsNCT06507748
What this trial is testing

Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

Who this might be right for
Neurofibromatosis Type 1
National Cancer Institute (NCI) 70
Not applicableStudy completedNCT05105100
What this trial is testing

Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma

Who this might be right for
MelanomaAdvanced Melanoma
University of California, San Francisco 25
Not applicableUnknownNCT04856514
What this trial is testing

Open Trial of Telehealth Group for Improving Peer Relationships (PEERS) in NF1

Who this might be right for
Neurofibromatosis 1Social Skills
University of Wisconsin, Milwaukee 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704
What this trial is testing

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Ended earlyNCT04239092
What this trial is testing

9-ING-41 in Pediatric Patients With Refractory Malignancies.

Who this might be right for
Refractory CancerRefractory NeoplasmCancer Pediatric+8 more
Actuate Therapeutics Inc. 40
Not applicableLooking for participantsNCT03745534
What this trial is testing

Cochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Results - a Pilot Study

Who this might be right for
Vestibular SchwannomaHearing Loss
Christoph Arnoldner 8
Not applicableLooking for participantsNCT04763109
What this trial is testing

Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence

Who this might be right for
Neurofibromatosis Type 1
Nicole Baca 15
Next Page